BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 6635957)

  • 1. [Smoldering indolent multiple myeloma].
    Andreeva NE
    Ter Arkh; 1983; 55(8):55-9. PubMed ID: 6635957
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
    Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
    Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-excretory plasma cell myeloma (apropos of 2 new cases)].
    Menkes CJ; Herreman G; Preud'homme JL; Godeau P; Delbarre F
    Nouv Presse Med; 1972 Jan; 1(5):309-12. PubMed ID: 4551593
    [No Abstract]   [Full Text] [Related]  

  • 4. Signet-ring plasma cell myeloma.
    Grier DD; Robbins K
    Am J Hematol; 2012 Jun; 87(6):625. PubMed ID: 21953819
    [No Abstract]   [Full Text] [Related]  

  • 5. [Multiple myeloma].
    Krome S
    Dtsch Med Wochenschr; 2012 Mar; 137 Suppl 1():S14-7. PubMed ID: 22438117
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow percentage of plasma cells in the staging of monoclonal gammopathies.
    Vercelli D; Di Guglielmo R; Guidi G; Scolari L; Buricchi L; Cozzolino F
    Nouv Rev Fr Hematol (1978); 1980; 22(2):139-45. PubMed ID: 7422542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of 2 prognostic classification systems for myeloma and examination of the correlation between initial bone marrow plasmacytosis and prognosis. A propos of a homogeneous population of 50 patients followed from diagnosis to death].
    Pesce A; Cassuto JP; Grisot C; Gratecos N; Bayle J; Viot G; Dujardin P
    Nouv Rev Fr Hematol (1978); 1983; 25(5):311-7. PubMed ID: 6657481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic soundness of the cytologic and histologic examination of the bone marrow in myeloma].
    Bettini R; Rapazzini P; Ferrari V; Ambruzzi AM; Mascalzi MG; Steidl L
    Recenti Prog Med; 1986; 77(7-8):357-61. PubMed ID: 3786936
    [No Abstract]   [Full Text] [Related]  

  • 9. [First manifestation of multiple myeloma as lethal streptococcal sepsis].
    Austein T; Kerstan H; Aue G; Schnieder I; von Bloh J; Badge S
    Med Klin (Munich); 2006 Nov; 101(11):905-7. PubMed ID: 17235478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoplasms of terminally differentiated B lymphocytes.
    Holbert JM
    Clin Lab Med; 1988 Mar; 8(1):197-210. PubMed ID: 3282759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Initial central nervous system involvement in a case of non-secretory multiple myeloma].
    Calavia J; Loyola I; Richard C; Baro J; Recio M; Cuadrado MA; Zubizarreta A
    Sangre (Barc); 1993 Oct; 38(5):389-91. PubMed ID: 8140502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgM multiple myeloma: more on a rare and heterogeneous disease.
    Cabrera Q; Chantepie S; Salaun V; Levaltier X; Troussard X; Macro M
    Am J Hematol; 2011 Aug; 86(8):717-8; author reply 718-9. PubMed ID: 21630314
    [No Abstract]   [Full Text] [Related]  

  • 13. [Optimizing plasma cell content in bone marrow aspirates].
    Hoffmann T; Favre G; Gratwohl A; Passweg J; Mathys S; Borel J; Speck B; Tichelli A
    Schweiz Med Wochenschr; 1998 Oct; 128(42):1611-3. PubMed ID: 9824893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conventional diagnostics in multiple myeloma.
    San Miguel JF; Gutiérrez NC; Mateo G; Orfao A
    Eur J Cancer; 2006 Jul; 42(11):1510-9. PubMed ID: 16762540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining IgM multiple myeloma.
    Owen RG; Feyler S; O'Connor SJ; Bond LR; de Tute RM; Rawstron AC
    Am J Hematol; 2011 Aug; 86(8):717; author reply 718-9. PubMed ID: 21761439
    [No Abstract]   [Full Text] [Related]  

  • 16. [Multiple myeloma -- diagnostics].
    Schroers R; Zettl F; Jung W
    Dtsch Med Wochenschr; 2005 Feb; 130(6):278-82; quiz 287-90. PubMed ID: 15692902
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of the results of immunological analysis of blood with clinical picture of multiple myeloma].
    Burghart-Czaplińska M; Hellmann A
    Wiad Lek; 1979 Jun; 32(12):827-31. PubMed ID: 506230
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical significance of bone marrow biopsy and plasma cell morphology in MM and MGUS.
    Bartl R; Frisch B
    Pathol Biol (Paris); 1999 Feb; 47(2):158-68. PubMed ID: 10192882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Smoldering multiple myeloma].
    Zapatero A; Blanco L; Sevilla F; Fraile G; Montalbán C
    Rev Clin Esp; 1985 May; 176(9):469-70. PubMed ID: 4023335
    [No Abstract]   [Full Text] [Related]  

  • 20. Digital image analysis of mean AgNOR area objectively discriminates between reactive plasmacytosis and multiple myeloma in cytologic smears from bone marrow aspirates.
    Gunia S; Mai PA; Koch S
    Pathobiology; 2008; 75(5):306-11. PubMed ID: 18931533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.